Clinical Trial Details

A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors

Complete Title: A Phase 1b, Multicenter, Open-Label Study of Valemetostat Tosylate in Combination with DXd ADCs in Subjects with Solid Tumors
Trial Phase: I
Investigator: Andrew Coveler

This study will evaluate the safety, tolerability, and efficacy of valemetostat tosylate in combination with DXd ADC in patients with advanced solid tumors.

Keywords:
  • Advanced Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.